Tag: exposure-adjusted incidence rate
Understanding Adverse Event Rates: Percentages and Relative Risk in Clinical Trials
Adverse event rates in clinical trials must account for exposure time to avoid misleading safety conclusions. Learn how IR, EIR, and EAIR differ, why the FDA now requires exposure-adjusted methods, and how relative risk calculations impact drug safety assessments.